Search results
Results from the WOW.Com Content Network
In general, the index consists of a minimum of 10 and a maximum of 20 companies traded at the Brussels Stock Exchange. Since 20 June 2011, the BEL20 has contained 20 listings, with the exception a one-month period in May–June 2018 when Ablynx stock was removed following the takeover by Sanofi , [ 1 ] only to be replaced mid June by arGEN-X ...
CECEEUR – Central European Clearinghouses & Exchanges Index, Composit Index in Euro. Composed of Polish Traded Index (PTX), Czech Traded Index (CTX) and Hungarian Traded Index (HTX) by the Vienna Stock Exchange. UBS 100 Index - the 100 Swiss companies with the largest market capitalizations that are listed on the SIX Swiss stock exchange.
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
In the European region, there are multiple stock exchanges among which five are considered major (as having a market cap of over US$1 trillion): . Euronext, which is a pan-European, Dutch-domiciled and France-headquartered stock exchange composed of seven market places in Belgium, France, Ireland, the Netherlands, Italy, Norway, and Portugal.
The Brussels Stock Exchange (French: Bourse de Bruxelles [buʁs də bʁysɛl]; Dutch: Beurs van Brussel [ˈbøːrs fɑm ˈbrʏsəl]), abbreviated to BSE, was founded in Brussels, Belgium, by decree of Napoleon in 1801. In 2002, the BSE merged with the Amsterdam, Lisbon and Paris stock exchanges into Euronext, renaming the BSE Euronext Brussels.
This is a list of major stock exchanges.Those futures exchanges that also offer trading in securities besides trading in futures contracts may be listed both here and in the list of futures exchanges.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
The NASDAQ Biotechnology Index is a stock market index made up of securities of NASDAQ-listed companies classified according to the Industry Classification Benchmark as either the Biotechnology or the Pharmaceutical industry. [1] A list of the 225 components of the index is published online.